As unregulated peptides grow in popularity, doctors warn of unknown risks ABC30 Fresno Peptides and BPC 157 for Pain: What's the deal? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives